يعرض 1 - 10 نتائج من 66 نتيجة بحث عن '"hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy]"', وقت الاستعلام: 0.65s تنقيح النتائج
  1. 1
    مورد إلكتروني
  2. 2
    مورد إلكتروني

    مصطلحات الفهرس: controlled study, coronary artery disease/dt [Drug Therapy], coronary artery disease/rh [Rehabilitation], coronary artery disease/th [Therapy], drug use, female, follow up, healthy diet, healthy lifestyle, heart rehabilitation, human, lipid blood level, lipoprotein blood level, major clinical study, male, middle aged, non ST segment elevation myocardial infarction/rh [Rehabilitation], non ST segment elevation myocardial infarction/th [Therapy], percutaneous coronary intervention, physical activity, physical inactivity, aged, prediction, priority journal, prospective study, sex difference, smoking, ST segment elevation myocardial infarction/rh [Rehabilitation], ST segment elevation myocardial infarction/th [Therapy], stable angina pectoris/rh [Rehabilitation], stable angina pectoris/th [Therapy], triacylglycerol blood level, unstable angina pectoris/rh [Rehabilitation], unstable angina pectoris/th [Therapy], acetylsalicylic acid/dt [Drug Therapy], angiotensin receptor antagonist/dt [Drug Therapy], antithrombocytic agent/dt [Drug Therapy], cholesterol/ec [Endogenous Compound], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], ezetimibe/dt [Drug Therapy], high density lipoprotein/ec [Endogenous Compound], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], lipid/ec [Endogenous Compound], Australia, thienopyridine derivative/dt [Drug Therapy], ticagrelor/dt [Drug Therapy], triacylglycerol/ec [Endogenous Compound], adult, low density lipoprotein cholesterol/ec [Endogenous Compound], cholesterol blood level, article, Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26999Test
    Heart Lung and Circulation
    Click here for full text options
    LibKey Link

  3. 3
    مورد إلكتروني
  4. 4
    مورد إلكتروني

    مصطلحات الفهرس: controlled study, coronary artery disease/dt [Drug Therapy], coronary artery disease/rh [Rehabilitation], coronary artery disease/th [Therapy], drug use, female, follow up, healthy diet, healthy lifestyle, heart rehabilitation, human, lipid blood level, lipoprotein blood level, major clinical study, male, middle aged, non ST segment elevation myocardial infarction/rh [Rehabilitation], non ST segment elevation myocardial infarction/th [Therapy], percutaneous coronary intervention, physical activity, physical inactivity, aged, prediction, priority journal, prospective study, sex difference, smoking, ST segment elevation myocardial infarction/rh [Rehabilitation], ST segment elevation myocardial infarction/th [Therapy], stable angina pectoris/rh [Rehabilitation], stable angina pectoris/th [Therapy], triacylglycerol blood level, unstable angina pectoris/rh [Rehabilitation], unstable angina pectoris/th [Therapy], acetylsalicylic acid/dt [Drug Therapy], angiotensin receptor antagonist/dt [Drug Therapy], antithrombocytic agent/dt [Drug Therapy], cholesterol/ec [Endogenous Compound], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], ezetimibe/dt [Drug Therapy], high density lipoprotein/ec [Endogenous Compound], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], lipid/ec [Endogenous Compound], Australia, thienopyridine derivative/dt [Drug Therapy], ticagrelor/dt [Drug Therapy], triacylglycerol/ec [Endogenous Compound], adult, low density lipoprotein cholesterol/ec [Endogenous Compound], cholesterol blood level, article, Article

  5. 5
    مورد إلكتروني

    مصطلحات الفهرس: article, cardiovascular disease, cardiovascular mortality, cerebrovascular disease, cohort analysis, diabetes mellitus, female, heart disease, heart infarction/dt [Drug Therapy], heart left ventricle ejection fraction, hospital mortality, human, major clinical study, male, middle aged, non ST segment elevation myocardial infarction, percutaneous coronary intervention, priority journal, risk assessment, sex difference, ST segment elevation myocardial infarction, acetylsalicylic acid/dt [Drug Therapy], acetylsalicylic acid/pv [Special Situation for Pharmacovigilance], angiotensin receptor antagonist/dt [Drug Therapy], angiotensin receptor antagonist/pv [Special Situation for Pharmacovigilance], antilipemic agent/dt [Drug Therapy], antilipemic agent/pv [Special Situation for Pharmacovigilance], beta adrenergic receptor blocking agent/dt [Drug Therapy], beta adrenergic receptor blocking agent/pv [Special Situation for Pharmacovigilance], clopidogrel/dt [Drug Therapy], clopidogrel/pv [Special Situation for Pharmacovigilance], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/pv [Special Situation for Pharmacovigilance], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], hydroxymethylglutaryl coenzyme A reductase inhibitor/pv [Special Situation for Pharmacovigilance], thienopyridine derivative/dt [Drug Therapy], thienopyridine derivative/pv [Special Situation for Pharmacovigilance], ticagrelor/dt [Drug Therapy], ticagrelor/pv [Special Situation for Pharmacovigilance], mortality rate, adult, aged, Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29033Test
    European Journal of Preventive Cardiology
    Click here for full text options
    LibKey Link

  6. 6
  7. 7
    مورد إلكتروني
  8. 8
  9. 9
    مورد إلكتروني

    مصطلحات الفهرس: article, cardiovascular disease, cardiovascular mortality, cerebrovascular disease, cohort analysis, diabetes mellitus, female, heart disease, heart infarction/dt [Drug Therapy], heart left ventricle ejection fraction, hospital mortality, human, major clinical study, male, middle aged, non ST segment elevation myocardial infarction, percutaneous coronary intervention, priority journal, risk assessment, sex difference, ST segment elevation myocardial infarction, acetylsalicylic acid/dt [Drug Therapy], acetylsalicylic acid/pv [Special Situation for Pharmacovigilance], angiotensin receptor antagonist/dt [Drug Therapy], angiotensin receptor antagonist/pv [Special Situation for Pharmacovigilance], antilipemic agent/dt [Drug Therapy], antilipemic agent/pv [Special Situation for Pharmacovigilance], beta adrenergic receptor blocking agent/dt [Drug Therapy], beta adrenergic receptor blocking agent/pv [Special Situation for Pharmacovigilance], clopidogrel/dt [Drug Therapy], clopidogrel/pv [Special Situation for Pharmacovigilance], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/pv [Special Situation for Pharmacovigilance], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], hydroxymethylglutaryl coenzyme A reductase inhibitor/pv [Special Situation for Pharmacovigilance], thienopyridine derivative/dt [Drug Therapy], thienopyridine derivative/pv [Special Situation for Pharmacovigilance], ticagrelor/dt [Drug Therapy], ticagrelor/pv [Special Situation for Pharmacovigilance], mortality rate, adult, aged, Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29033Test
    European Journal of Preventive Cardiology
    LibKey Link

  10. 10